November 30, 2017 / 12:11 PM / 16 days ago

BRIEF-Shire says FDA Grants Shire Orphan Drug Designation For Investigational Anti-Madcam Antibody SHP647

Nov 30 (Reuters) - Shire Plc:

* ‍U.S. FDA GRANTS SHIRE ORPHAN DRUG DESIGNATION FOR INVESTIGATIONAL ANTI-MADCAM ANTIBODY SHP647

* ‍INVESTIGATIONAL ANTI-MADCAM ANTIBODY SHP647 FOR TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN PEDIATRIC PATIENTS​ Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below